Study of HS-10384 in Participants of Chinese Postmenopausal Women

Exclusion Criteria

• •1. Participants with disease history of uterine bleeding, uterine ovarian tumor, pituitary tumor, or other diseases evaluated by the principal investigator as not suitable for this study;
• •2. Have a history of migraine within 3 months before screening;
• •3. Participants with clinically significant diseases (such as neuropsychiatric system, cardiovascular system, urinary system, digestive system, respiratory system, skeletal muscle system, endocrine and metabolic system, blood system, skin disease, immune system, tumor, etc.) were evaluated by the researcher as not suitable for this study;
• •4. Within 2 weeks before screening, participants have suffered from VMS that inducing the interrupt of daily activities;
• •5. Within 30 days before taking drug, participants have taken hormonal treatment or other therapy due to VMS;
• •6. Within 4 weeks or 5 half-lives (whichever is longer) before screening, and during the whole study period, it is expected to take any medicine and health care products, including prescription drugs, immunomodulator or Chinese herbal medicine, etc.;
• •7. Within 3 months before screening, participants have taken hormonal contraceptive;
• •8. Participants have participated in any clinical study or taken study drugs within 3 months before screening;